Apollo Therapeutics

Series-B+
apollotx.com Biotech & Healthcare Cambridge, United Kingdom 51-100
Total Funding $226.5M
Latest Round $226.5M Series-B+
Last Announced Sep 6, 2023
Investors Undisclosed
Decision Makers 1 Verified

About Apollo Therapeutics

Apollo Therapeutics is a portfolio biopharmaceutical company that develops new medicines. It translates breakthroughs in biology and basic medical research into novel therapeutics. The company identifies and advances pre-clinical and clinical-stage therapeutic programs.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United Kingdom
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website apollotx.com
Domain Registered Date Mar 21, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $226,500,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    Website domain registered

    apollotx.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Apollo Therapeutics.

Funding History

1 Round
Series-B+ · Sep 6, 2023

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts